Role of cytosolic phospholipase A 2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells
Noriaki NAKATANI* 1 , Naonori UOZUMI*, Kazuhiko KUME*, Makoto MURAKAMI †, Ichiro KUDO † and Takao SHIMIZU* ‡ mice led to the release of negligible amounts of arachidonic acid or its metabolites, the cysteinyl leukotrienes and prostaglandin D # , indicating an essential role for cPLA # in the production of these allergic and pro-inflammatory lipid mediators. In addition, the histamine content of the mast cells and its release from the cells were reduced to 60 %. While these results are in agreement with
INTRODUCTION
Phospholipase A # (PLA # ) liberates fatty acids from the sn-2 position of glycerophospholipids, with the concomitant production of lysophospholipids. The arachidonic acid (AA) and lysophospholipids thus released are potential precursors of various types of eicosanoids and of platelet-activating factor (PAF) respectively. PLA # consists of a superfamily of more than 10 distinct molecular species of enzymes [1] [2] [3] . Among these, cytosolic PLA # (cPLA # ) is pre-eminent, because of its preference for AA. cPLA # is activated by submicromolar concentrations of calcium ions and by phosphorylation by mitogen-activated protein kinase [4] [5] [6] . To understand the roles of the enzyme in i o, mice lacking cPLA # (cPLA V / V # mice) have been established by gene targeting [7, 8] . The mice mature normally, but when sensitized and challenged they have lowered anaphylactic responses to ovalbumin and diminished bronchial hyperreactivity compared with wild-type animals [7] .
Antigen-specific activation through IgE on mast cells is considered to be responsible for allergic responses [9, 10] . The crosslinking of a high-affinity IgE receptor (FcεRI) expressed on the cell surface initiates the secretion of pro-inflammatory mediators that are pre-stored in granules (such as histamine, 5-hydroxytryptamine, heparin and vasoactive peptides), whereas lipid mediators such as prostaglandins, leukotrienes and PAF are synthesized de no o [10, 11] . It is now believed that the mast cells a reduced anaphylactic phenotype of cPLA V / V # mice, the ratios of release of histamine and β-hexosaminidase were, paradoxically, significantly higher for cells from cPLA
mice than for those from wild-type mice. Consistently, IgE-induced calcium influx in mast cells was greater and more prolonged in cells from cPLA V / V # mice than in those from wild-type mice. Thus the loss of cPLA # not only diminishes the release of lipid mediators, but also alters degranulation. While the overall effect is still a decrease in the release of mast cell mediators, explaining the in i o findings, the present study proposes a novel link between cPLA # and the degranulation machinery.
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enter the circulation from the bone marrow as mononuclear cell precursors and migrate into tissues under the influence of local microenvironmental factors, where they undergo the final steps of differentiation and maturation into recognizable mast cells [10] .
Bone-marrow-derived mast cells (BMMC) obtained under special culture conditions represent a relatively immature population of mast cells that have been used widely as a model of mast cells [12] [13] [14] [15] [16] [17] [18] . We used BMMC obtained from cPLA +/+ # and cPLA V / V # mice, and measured the secretion of mediators from the cells after stimulation with an antigen. With cells from cPLA
mice, the amount of mediators was significantly reduced. A paradoxical finding was that BMMC from cPLA V / V # mice showed augmented exocytosis of histamine and lysosomal enzymes upon IgE stimulation, but, because they contained lower levels of histamine, the absolute amount of histamine released was less than from wild-type cells. These results may prove useful in the development of cPLA # inhibitors, and in interpreting the therapeutic effects of such inhibitors in allergic and inflammatory disorders.
EXPERIMENTAL Materials
Partial fragments of cDNAs for mouse mast cell protease-1 (MMCP-1), MMCP-4 and MMCP-5 were obtained from a murine BMMC cDNA library [19] [20] [21] . WEHI-3 cells were obtained from A. T. C. C. FITC-labelled IgE and allophycocyanin-labelled anti-c-Kit antibody were generously donated by Dr C. Ra (Juntendo University, Tokyo, Japan 
Mouse BMMC culture
Bone marrow cells from cPLA +/+ # and cPLA
littermates (6-7-week-old females) were cultured for 4-8 weeks in 50 % WEHI-3 cell conditioned medium\50 % RPMI 1640 supplemented with 10 % (v\v) fetal calf serum, 0.1 mM non-essential amino acids, 100 units\ml penicillin and 100 mg\ml streptomycin [16] .
Light microscopy of BMMC
The cultured mast cells were centrifuged with Cytospin 3 (Shandon, Astmoor, U.K.) at 28 g for 5 min, and stained with safranin (0.1 %, w\v) in 0.3 % acetic acid solution and Alcian Blue (0.5 %, w\v) in 0.1 % acetic acid solution.
Electron microscopy of BMMC
Electron microscopy analyses were carried out following fixation of BMMC in 5 % (v\v) glutaraldehyde, post-fixing in 1 % (w\v) osmium tetroxide, embedding in epoxy resin and slicing to 60-90 nm thickness. Samples were stained with lead citrate and uranium acetate, and viewed with a transmission electron microscope (Hitachi-H600 ; Hitachi, Tokyo, Japan).
Flow cytometry of BMMC
Expression of FcεRI and c-Kit was assessed by FACS, with FITC-labelled IgE and allophycocyanin-labelled monoclonal anti-mouse c-Kit antibody respectively. Background staining was measured with propidium iodide.
Stimulation of BMMC
BMMC were suspended at a density of (0.5-1)i10( cells\ml in an enriched medium containing 50 % (v\v) WEHI-3 conditioned medium, and sensitized with 2.5-5 mg\ml anti-Dnp IgE for 30 min at 37 mC. After being washed twice, cells were resuspended in enriched medium at a density of (1-5)i10' cells\ml and incubated at 37 mC with various concentrations of Dnp-HSA. Cells were placed on ice to terminate the reaction, and then centrifuged at 3000 g for 5 min at 4 mC to obtain supernatants. The supernatants were assayed for PGD # by RIA, and for cysteinyl-leukotrienes, histamine and 5-hydroxytryptamine by enzyme immunoassay. The production of PAF was determined as described [22] . For measurement of released AA, cells at a density of 1i10' cells\ml were prelabelled with [$H]AA (5 µCi\well) overnight, and were sensitized with anti-Dnp IgE for 30 min. After washing, the cells were incubated with 50 ng\ml Dnp-HSA at 37 mC, and the radioactivity in the medium was counted with a scintillation counter. The activity of β-hexosaminidase was quantified in the supernatants and cell pellets by spectrophotometric analysis using p-nitrophenyl Nacetyl-β--glucosaminide as a substrate [16] . The percentage of β-hexosaminidase released was calculated from the formula S\(SjP)i100, where S and P are the β-hexosaminidase contents of equal portions of each supernatant and cell pellet respectively.
Measurement of intracellular free calcium concentration ([Ca
' cells\ml] sensitized with anti-Dnp IgE were loaded with 3 mM fura 2 acetoxymethyl ester (fura 2\AM) (Dojin, Kumamoto, Japan) in RPMI 1640 at 37 mC for 1 h. The cells were then washed and resuspended in Hepes\Tyrode's buffer at 1i10' cells\ml in a stirred cuvette. The fura 2\AM-loaded cells were stimulated with Dnp-HSA at 37 mC. The fluorescence of the cell suspension was monitored continuously using CAF-100, a calcium analyser (JASCO, Tokyo, Japan), with excitation at 340 nm and 380 nm, and emission at 500 nm.
RESULTS

Bone marrow cells from cPLA V/V 2 mice grow normally into BMMC
Bone marrow cells were prepared from 6-7-week-old F2 littermates. After 5 weeks of culture they were evaluated by staining with Alcian Blue\safranin ( Figure 1A ). Heterogeneous staining was observed in cells from both genotypes, which reflects differential expression of the various granule proteoglycans [19] . (Figures 2A and 2B) . negligible ( Figures 3B and 3C ). On the other hand, PAF production was only slightly decreased in cPLA Figure  3D ).
Histamine release and content are decreased in BMMC from cPLA V/V 2 mice
Histamine is one of the mediators involved in the immediate phase of allergic responses, such as constriction of bronchial and intestinal smooth muscles, increased vasopermeability and vaso- Figures 5C and 5D ). In contrast with histamine, however, the total content of β-hexosaminidase in the resting cells did not vary with genotype (results not shown). 
DISCUSSION
BMMC from cPLA V / V # mice were successfully cultured to obtain populations of mast cells, as seen on staining with Alcian Blue\safranin ( Figure 1A) . Electron microscopy showed that cells from cPLA
mice were morphologically indistinguishable from those from cPLA +/+ # mice ( Figure 1B ). The two cell types expressed FcεRI and c-Kit on the cell surface to equal extents (Figure 2 ). MMCP-1 and MMCP-5 were expressed similarly in both cell types (results not shown). These findings indicate that cPLA # is not essential for the differentiation of mast cells in itro, and that the events following the cross-linking of receptors on the membrane seem to occur equivalently in cPLA +/+ # and cPLA V / V # cells (except for histamine content, as discussed below). Mast cells contain at least three different types of PLA # , i.e. cPLA # , secretory PLA # (sPLA # ) (group IIA and group V ) and calcium-independent PLA # [13, 15, 26] . BMMC of both genotypes used in the present study do not express group IIA PLA # , because they are derived from F2 offspring of 129\Ola and C57BL\6J mice [27, 28] . Bingham et al. [29] showed that C57BL\6J-derived BMMC produce considerable amounts of PGD # during delayed-phase responses, as seen with BALB\cJ-derived BMMC which have normal alleles for group IIA PLA # .
On the other hand, the production of PGD # in 129\J-derived BMMC was minimal during the delayed-phase reaction. Since the cells used here were from mice of the F2 generation, which show the greatest variation compared with their grandparents, we did not investigate delayed-phase responses using these mice. Since immediate-phase responses are less influenced by genetic background, the focus of the present study was immediate-phase responses. When BMMC were stimulated with an antigen, release of AA into the medium was suppressed to background levels in cPLA Figure 3A) . Production of cysteinyl-leukotrienes and PGD # was observed in cPLA +/+ # cells, but not in cPLA (Figures 3B and 3C) . Thus cPLA # supplies AA to cyclooxygenases and lipoxygenases in the immediate response of mast cell activation. While previous reports using inhibitors and antibodies have suggested a role for sPLA # in the immediatephase production of eicosanoids in mouse MMC-34 mastcytoma cells [14] , our present results suggest a dominant role for cPLA # in these responses. This difference might be due to the use of different types of mast cell (mastcytoma cells compared with BMMC), a different experimental protocol (inhibitors\antisense compared with gene targeting), or both. Fujishima et al. [30] also suggested an important role for cPLA # in immediate-phase eicosanoid production. With regard to PAF, its production was only partially decreased in cPLA Figure 3D ), suggesting that PAF is also synthesized via cPLA # -independent pathways, such as de no o synthesis or CoA-independent transacylation [31] .
The histamine content and absolute amount of histamine released were decreased in cPLA Figure 4 ). To elucidate the mechanisms responsible for the decreased histamine content, we first measured the mRNA levels of -histidine decarboxylase (HDC), which converts histidine into histamine. HDC transcripts are expressed equally in both genotypes of cells (N. Nakatani, unpublished work). As shown by metabolic labelling experiments using [$&S]methionine, the amount of HDC protein appears to be lower in cPLA V / V # cells (N. Nakatani, unpublished work). HDC protein is synthesized as an inactive immature form in mast cells, is converted into a mature form by proteolytic processing, and is transported to vesicular compartments [32] . Although the molecular mechanism remains elusive, the cPLA # product may change the stability of the protein and\or the translational regulation of HDC. Taken together with the decreased amounts of lipid mediators, these data support the proposal that changes in the properties of mast cells are the cause of the reduced reactions of anaphylaxis that we described previously in cPLA V / V # mice [7] . A recent study has shown that PGD # is a mediator of allergic responses [33] .
Unexpectedly, the percentage release of histamine was greater with cPLA V / V # cells than with cPLA +/+ # cells ( Figures 5A and 5B) . Similarly, the release of β-hexosaminidase was increased in cPLA Figures 5C and 5D ). In contrast with histamine, since the total cellular content of β-hexosaminidase was equivalent in two cell types, the absolute amount of enzyme released was increased in cPLA
In an attempt to suppress the enhanced degranulation, we added a series of eicosanoids, or various lysophospholipids which may be produced by cPLA # in activated mast cells, to the culture medium, but none of these lipids suppressed the enhanced degranulation in cPLA V / V # cells (results not shown). Degranulation is the consequence of two steps, i.e. tyrosine phosphorylation and calcium mobilization, in which a number of molecules are involved. FcεRI consists of one α-, one β-and two γ-subunits, and the β-and γ-subunits have an immunoreceptor tyrosine-based activation motif (ITAM) in their C-termini, which is phosphorylated and activated by Src-family kinases. The aggregation of FcεRI leads to the phosphorylation and\or activation of several protein tyrosine kinases (Lyn, Syk, Btk, etc.) [18, [34] [35] [36] [37] [38] [39] . Several investigators have suggested that the release of AA from a mast cell line is due to the activation of cPLA # by mitogen-activated protein kinase, while the release of β-hexosaminidase is regulated primarily by Ca# + and protein kinase C [18, 40] . The present study clearly shows that the two pathways are not completely independent, and that cPLA # or its products appear to be involved in the regulation of the exocytotic pathway by as yet unknown mechanisms. As shown in Figure  6 (A), cells of both genotypes responded to Dnp-HSA with an elevation of [Ca# + ] i . The increase in [Ca# + ] i was mostly due to calcium influx ( Figure 6D ). The [Ca# + ] i response was greater and more prolonged in cPLA
cells, which appears to parallel the increase in degranulation. Although the mechanisms behind prolonged [Ca# + ] i responses remain unclear, a similar pattern was observed in BMMC from SH2-containing inositol 5h-phosphatase (SHIP)-deficient mice [41, 42] , in which the elevation in [Ca# + ] i lasted much longer than normal. Further studies on signalling molecules between FcεRI and calcium influx would clarify the target of cPLA # products. In addition, there is a large body of evidence implicating protein kinase C, Rab-family kinases, SNAP (soluble N-ethylmaleimide-sensitive factor attachment protein) and phospholipase D as regulators of mast cell degranulation [43, 44] . Either a cPLA # product or cPLA # itself might interact with and regulate the functions of these molecules. Our results, therefore, indicate a novel link between two different mast cell functions, i.e. degranulation and the production of lipid mediators. Enhanced degranulation of β-hexosaminidase in cPLA V / V # BMMC was also reported by Fujishima et al. [30] , although the mechanism was not described in detail.
In conclusion, BMMC from cPLA V / V # mice showed decreases in AA release and in the production of eicosanoids and PAF. The cellular histamine content and, therefore, the amount of histamine released after stimulation with the antigen were decreased. Thus the reduced anaphylactic symptoms in these mice are due, at least in part, to this decreased mast cell function. In addition, our study suggests that the cPLA # pathway is also involved in degranulation. Further studies are required in order to demonstrate how cPLA # regulates IgE-dependent calcium influx and degranulation.
